| Literature DB >> 25686373 |
Jürgen Lassak1, Eva C Keilhauer2, Maximilian Fürst1, Kristin Wuichet3, Julia Gödeke4, Agata L Starosta5, Jhong-Min Chen6, Lotte Søgaard-Andersen3, Jürgen Rohr6, Daniel N Wilson5, Susanne Häussler7, Matthias Mann2, Kirsten Jung1.
Abstract
Ribosome stalling at polyproline stretches is common and fundamental. In bacteria, translation elongation factor P (EF-P) rescues such stalled ribosomes, but only when it is post-translationally activated. In Escherichia coli, activation of EF-P is achieved by (R)-β-lysinylation and hydroxylation of a conserved lysine. Here we have unveiled a markedly different modification strategy in which a conserved arginine of EF-P is rhamnosylated by a glycosyltransferase (EarP) using dTDP-L-rhamnose as a substrate. This is to our knowledge the first report of N-linked protein glycosylation on arginine in bacteria and the first example in which a glycosylated side chain of a translation elongation factor is essential for function. Arginine-rhamnosylation of EF-P also occurs in clinically relevant bacteria such as Pseudomonas aeruginosa. We demonstrate that the modification is needed to develop pathogenicity, making EarP and dTDP-L-rhamnose-biosynthesizing enzymes ideal targets for antibiotic development.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25686373 PMCID: PMC4451828 DOI: 10.1038/nchembio.1751
Source DB: PubMed Journal: Nat Chem Biol ISSN: 1552-4450 Impact factor: 15.040